Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MerLion Pharmaceuticals

Request full access

Researches and develops drugs based on natural products

Berlin, GermanyFounded 2000Biotech & Life Sciences

About MerLion Pharmaceuticals

Merlion Pharmaceuticals is a biotechnology company dedicated to the development of innovative antibiotics aimed at addressing the growing threat of bacterial infections in both humans and animals. The company operates in the pharmaceutical and biotechnology sector, focusing on creating solutions for complex urinary tract infections (cUTI), ear infections, and biodefense against biothreat agents. Merlion's business model revolves around research and development, clinical trials, and regulatory approvals to bring their antibiotic candidates to market. Revenue is generated through the commercialization of approved drugs, partnerships with defense agencies, and collaborations with healthcare institutions. Key clients include hospitals, veterinary clinics, and government defense agencies. The company has achieved significant milestones, including US FDA and Health Canada approval for their finafloxacin-based treatments. Merlion's strategic partnerships, such as with the UK Defence Science and Technology Laboratory and the US Defense Threat Reduction Agency, further bolster their market position.

Source: Dealroom company data

MerLion Pharmaceuticals in the Berlin ecosystem

Live from Dealroom

The MerLion Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Aravis Ventures
  • Novartis Venture Fund
  • Lacuna
  • ZKB - Zürcher Kantonalbank

Series B and later3 investors entered at this stage

  • Heidelberg Capital Private Equity
  • Bio*One Capital
  • Aurelia Private Equity
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇩🇪 Germany83.3%
🇨🇭 Switzerland16.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MerLion Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MerLion Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.